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Dicarboxylic acids from Cs to C I4 are competitive in-
hibitors of tyrosinase in vitro, and here, the effect of a 
cream containing 15% azelaic acid (Cu) on 3 cases of 
lentigo maligna is described. The lesions were treated 
for 90 days, with remarkable clinical and histological 
effect, maintained for up to 2 yr after cessation of treat-
ment. Progress during treatment of one case was addi-
tionally monitored by electron microscopy, which re-
vealed progressive elimination of abnormal melanocytes 
both bas ally and suprabasally, and their replacement by 
essentiitlly normal cells engaged in normal melanoge-
nesis. There was also progressive diminution in the gen-
eral disorganization of the epidermis, and disappearance 
oflymphocyte response. It is concluded that dicarboxylic 
acids have a direct inhibitory and cytotoxic effect on 
abnormally active or structurally disordered melano-
cytes in lentigo maligna, but further investigations are 
required to establish their precise mode of action. Simi-
lar application of dicarboxylic acids to normal skin af-
fects only a small proportion of melanocytes, suggesting 
that some phasic factor, or individual states of activity, 
may be concerned in their susceptibility. 
Focal depigmentation of skin, sometimes preceded by tran-
sient hyperpigmentation, is a characteristic feature of Pityriasis 
versi.color and is accompanied by cytologic alterations in mel-
anocytes [1]. In previous reports [2,3] we have provided evi-
dence which indicates that the hypochromia may result from 
tyrosinase inhibition and damage to melanocytes by products 
formed through the oxidation by a Pityrosporum enzyme sys-
tem of the double-bond linkages of unsaturated fatty ' acids 
normally present in skin surface lipids. Recently [4], we have 
conclusively established that in cultures of Pityrosporum, sup-
plemented with oleic or vaccenic acid, the oxidation products 
in question are competitive inhibitors of, and not alternative 
substrates for tyrosinase, and have identified them as dicarbox-
ylic acids, notably, azelaic acid (C'J dicarboxylic acid) and do-
decandioic acid (C 12 dicarboxylic acid). We have also estab-
lished that commercial pure standard dicarboxylic acids from 
Cg to C 1'1 are similarly capable of inhibiting tyrosinase activity 
to varying extents, and the overall observations raise the pos-
sibility that these substances might prove of therapeutic value 
in the treatment of hyperpigmentary disorders of skin. Accord-
ingly, a cream containing Cn dicarboxylic acid was prepared and 
applied to patients with lentigo maligna, and the results are 
described in this report. 
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MATERIALS AND METHODS 
Three patients, aged 65, 87 and 58, with facial lentigo maligna of 7, 
10 and 8 yr duration respectively, were treated. They were given a 
cream containing 15% azelaic acid (C" dicarboxylic acid) in a standard 
base (Cetyl alcohol, 3%; Twee~ 80, 5%; Sodium-Iauryl-sulfate, 10%; 
Ethanolamine-Iauryl-sulfate, 10%; olive oil, 2%; vitamin C, 1%; distilled 
water, q.b.) and instructed to rub it well into the affected areas of the 
skin twice daily for 90 days. In 2 cases, progress throughout treatment 
and up to 2 yr after its cessation was assessed by clinical and histological 
examination. With the third case, progress during treatment was mon-
itored by light and electron microscopic observation of material re-
moved at staged biopsies, taken before commencement, after 6 weeks 
application of the cream, and at cessation, after 90 days of continuous 
treatment. Each biopsy was divided in to 2 portions. One portion was 
fixed for histological examination in 10% formol saline, and sections 
were stained with hematoxylin and eosin; DOPA-incubated material 
was not prepared, since the condition of the melanocytes was addition-
ally being assessed ul trastructurally. The other biopsy portion was fixed 
in buffered 2.5% glutaraldehyde, post-osmicated, dehydrated, and em-
bedded in TAAB resin for electron microscopy. 
A similar 15% azelaic acid cream was applied twice daily for 90 days 
to forearm skin of 2 male volunteers- one heavily freckled, the other 
of a complexion type which tans moderately,-and material taken at 
biopsy before application, and at 2 weekly in tervals, was processed as 
above fo r examination by electron microscopy. 
RESULTS 
Clinical 
The highly satisfactory results achieved by treatment of the 
lentigo maligna lesions for 90 days is seen in Fig 1, and it may 
be emphasized that in the first 2 cases, the affected areas of 
skin continue to appear normal 2 years after cessation of treat-
ment. 
During the first 10 days or so of treatment, a transitory mild 
inflammatory reaction with some desquamation was observed 
in all cases but otherwise no side effects of either toxic or 
allergic nature were observed. Clinical improvement during 
treatment was characterized by progressive diminution in in-
tensity of pigmentation, rather than by actual reduction in size, 
or shrinkage, of the lesion. Apparent shrinkage can result from 
the initial existence within lesions of areas of different degrees 
of melanization, the lighter of which, revert to normal at an 
earlier stage. Intensely black areas become brown or yellowish-
brown before entirely losing their pigmentation, and this type 
of alteration gave a good early indication that treatment was 
likely to be successful. 
No effect or reaction whatsoever was observed during appli-
cation of the cream to normal skin of the 2 volunteers, either 
on plain naked-eye observation, or on examination under 
Wood's light. No hypo- or hyperpigmentation was observed, 
nor were freckles altered in any way, and the same applies at 
the time of writ ing, more than one year after cessation of the 
experiment. 
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FIG 1. Lent igo maligna treated by da ily application of azela ic acid cream for 90 days. A, case I, of 7 yr duration, before t reatment. B, same case 
2 yr after cessation of treatment. C, case 2, of 10 yr duration, before treatment. D, same case 2 yr after cessation of treatment. E, case 3, of 8 yr 
duration, before treatment. F, same case some months after cessation of treatment. The patient did not use a mirror while applying the cream. 
so t h e post.e rior and lower areas of the lesion were less effec tively treated; a good internal cont rol of the effect of the therapy. (Fig I a and b 
rep roduced, with permission, from Nazzaro-Porro et. al. Pigment Cell, vo l 4, Karger, Basel, 1979. ) 
Histology 
In all 3 patients with lentigo malign a t he init ial pretreatment 
histological picture was essentially similar. In many sections a 
characteristic feature of the lesion was the presence of pleo-
morphic and atypical melanocytes wi thin the junctional zone 
of t h e epidermis with fo rmation of nests surrounded by spaces 
(Fi g 2A ). In the superficial dermis t here was a round cell 
inflammatory infiltrate and many melanophages loaded with 
mela nin were present. T aking the overall appearances, the cases 
t reated here could be designated as group B lesions of the 
classification of Clarke at al [5,6], bu t they might also be 
considered to have some features of group C lesions. 
After 6 weeks of topical t reatment wit h azelaic acid, in all 3 
patients, nest fo rmation was very much less evident, though the 
number of melanocytes in the basal layer of the epidermis was 
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FIG 2. Lentigo maligna, case 3, A, before treatment. Nests of a bnor-
mal melanocytes in epidermis with round ceU infiltration a nd melano-
phages in superficia l dermis. B, after 6 weeks treatment with azelaic 
ac id cream. Abnormal melanocytes still present in basal layer of epi-
dermis, but nests no longer evident; dermal inflammatory reaction less 
prominent. C, after 3 mo treatment. Epidermis appears essentially 
normal, and the epidermal-dermal junction is clearly defined. Melano-
cytes, if a nything, less than normal in number. In the dermis, only a 
few lymphocytes a nd some macrophages are evident. 
still evidently greater than normal (Fig 2B). Some of these 
melanocytes exhibited a foamy appearance of the cytoplasm. 
The dermal inflammatory reaction ~as significantly less prom-
inent than before treatment. 
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In all 3 cases, following 3 mo of treatment, the epidermis 
appeared essentially normal, though slightly hyperplastic, and 
the epidermal-dermal junction was clearly defined and delim-
ited (Fig 2C). The inflammatory inflltrate in the upper dermis 
was greatly diminished, and represented only by a few lympho-
cytes and macrophages, with an increased number of new 
capillaries and fibroblasts. The epidermal melanocytes mani-
festing as "clear cells," appeared, if anything, reduced in number 
and apparently normal. Impressions of this latter nature, how-
ever, derived from routinely stained histological sections, must 
be treated with caution, but in the present instance they were 
further assessed at the ultrastructural level, which provides 
clear-cut criteria for pronouncing upon the morphology and 
functional activity of melanocytes. 
Electron microscopy 
Lentigo maligna before treatment: As may be seen from the . 
micrographs (Fig 3-5), the lesion in the thi.rd case before 
treatment exhibited the following features: (1) Active prolifer-
ation and increase in number of epidermal melanocytes with 
formation of basal theques and presence of many melanocytes 
supra basally. (2) Lymphocyte response and round-cell inflltra-
tion of epidermis. (3) Amorphous material between cells, both 
keratocytes and melanocytes; these 3 features led, in places to 
considerable disorganization of the epidermis. (4) Pleomorphy 
of melanocytes with many exhibiting swollen and vacuolated 
mitochondria, numerous Golgi membranes, foci of necrosis in 
the cytoplasm, indented nuclei, with large nucleoli; melano-
somes were in general ellipsoid in form and fully melanized, 
though vacuolar or aborted melanosomes were present in some 
cells. (5) Isolated melanocytes in the dermis just beneath the 
epidermis. (6) Many dermal macro phages stuffed with mela-
nosomes, and round-cell inflltration of the dermis. 
It must be stated that a number of the features listed would 
be regarded as indicative of malignancy by some authors 
[5-12]. 
Lentigo maligna after treatment (or 6 weehs: Biopsy was 
performed at 2 sites of different degrees of pigmentation. In the 
less heavily pigmented area the picture was fairly uniform. The 
epidermis was no longer disorganized to any extent, and lym-
phocytes or smaller round cells were only very occasionally 
seen; the general level of pigmentation was considerably less 
than before treatment (Fig 6). Whereas more basal melanocytes 
were present than in normal epidermis, the ques were absent, 
and suprabasal melanocytes few. Some melanocytes were 
shrunken and surrounded by amorphous material, or exudate, 
and the majority of those present had significantly fewer and 
less melanized melanosomes than those present previously. A 
highly characteristic feature of many melanocytes was the 
occurrence of numerous lipid droplets in the cytoplasm, and 
most of the mitochondria were swollen and vacuolated (Fig 7). 
In the more heavily pigmented area the epidermal appear-
ances were more variable. Whereas in some blocks they were 
similar to that described above, and in places resembled even 
more the normal, in others, they resembled more the condition 
before treatment, though not nearly to the same degree of 
abnormality. In one situation, appearances were as if a theque 
of abnormal melanocytes, such as that illustrated in Fig 4 of 
the control, had ruptured into the dermis as a result of a build-
up of amorphous material or exudate between the cells. 
Fewer round cells and macrophages were observed in the 
dermis, but the occasional dermal melanocyte was still present. 
Considering the overall appearances, a significant improvement 
in the condition at the ultrastructural level was apparent, as 
compared with the control before treatment. 
Lentigo maligna after 3 months of treatment: Biopsy per-
formed after a further 8 weeks of treatment showed the general 
organization of the epidermis to be practically normal (Fig 8,9). 
Basal melanocytes were present in apparently normal numbers, 
and, apart from swelling of some mitochondria of some cells, 
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F IG 3. Lentigo meligna, case 3, before treatment. Basal layers of epidermis and epidermal-dermal junctional region. The epidermis is 
disorganized by presence of excessive numbers of abnormal melanocytes (M) of variable appearance, lymphocytes (L), and amorphous exudate 
(E) among the keratocytes (K). Note a lso melanocytes in dermis. Scale = 8 I'm (x 2,500) . 
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FIG 4. Lentigo maligna, case 3, before treatment. A theque of abnormal, pleomorphic, and heavily melanized melanocytes is present in the 
epidermis. A rrows indicate epidermal-dermal junction, which is disrupted in places. E, amorphous exudate; K, keratocyte, of which very few are 
present. Scale = 6.6 /-1m (x 3,000). 
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FIe 5. Lentigo maligna, case 3, before treatment. Melanocyte of 
type predominantly and typically present in the lesion. The nucleus is 
indented, with prominent nucleolus, Golgi membranes (G) are numer-
ous, melanosomes are heavily melanized and mainly ellipsoid in shape, 
and there is an area of necrosis (Ne) in the cytoplasm. Scale = 2 /.1m 
(x 9,500). 
and the occasional vacuole of doubtful ongm in others, ap-
peared morphologically normal. Some melanocytes exhibited 
minimal melanogenic activity, containing only a few stage 1 
melanosomes, and on this basis, and by virtue of nuclear and 
general cytoplasmic features, could be regarded as "young 
cells_" Others were moderately active, and melanogenesis ap-
peared to be proceeding normally with the production of mel-
anosomes of normal size, shape, and internal structure (Fig 10) . 
Suprabasal melanocytes were not present, and there was no 
abnormal lymphocyte response. The epidermal basal lamina 
was completely intact, and just deep to it, there were broken 
fragments of previous basal laminar material, indicating repair 
and reconstitution of the epidermal-dermal junction (Fig 9) . 
Melanin-filled macro phages were present in the dermis, and 
there were still some melanocytes seen in this location. 
Normal Skin: The great majority of melanocytes of both 
subj ects observed in all biopsies taken during application of the 
cream presented an ultrastructural appearance well within the 
range of normality as seen in control specimens taken at the 
saIne time. Isolated melanocytes, however, especially in biopsies 
taken at 3 and 4 weeks of application (Fig 11) exhibited degen-
erative features of a degree not seen in the present controls, nor 
in Inelancoytes of normal skin generally. The ultrastructure of 
the epidermal keratocytes appeared unaltered by application of 
the cream (Fig 11). 
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DISCUSSION 
Lentigo maligna is not a purely functional hyperpigmentary 
disorder, but one in which there is active proliferation of ab-
normal melanocytes, and, ultimately, malignant transformation 
[6]. Whereas some degree of spontaneous regression can occur 
in this condition, it seems highly unlikely that this could ac-
count for the present dramatic results. The lesions were present 
for many years in each case, and for spontaneous regression of 
this total degree to occur just as the dicarboxylic acid cream 
was being applied, seems too great a coincidence to accept. It 
seems reasonable to conclude that the improvements achieved, 
i.e., disappearance of abnormal melanocytes, and the re-ap-
pearance of normal ones with return to normal of the general 
organization of the epidermis and reconstruction of the epider-
mal-dermal junctional region, was a direct result of therapy. 
Clearly it is important from many points of view to establish 
the precise mode of action of dicarboxylic acids in destroying or 
eliminating abnormal melanocytes, but the present ultrastruc-
tural observations throw little light upon this question. The 
abnormal, heavily melanized cells, predominantly present at all 
epidermal levels in the untreated lesion had largely disappeared 
by the time of the first biopsy, and more frequent biopsies 
beginning closer to the start of treatment in future cases will be 
necessary to provide further information and grounds for spec-
ulation. However, a feature of many of the melanocytes still 
present at the first biopsy may provide a clue. This was the 
occmrence of numerous lipid droplets within the cytoplasm. 
Isolated lipid droplets occasionally occur in normal and malig-
nant melanocytes, but never to anything like the extent seen 
here. A similar massive build-up and confluence of lipid droplets 
with subsequent cellular disruption has been observed to occur 
in malignant melanocytes of Harding-Passey mouse melanoma 
following intraperitoneal injection or oral administration of 
dicarboxylic acids [13,14]. It may be that dicarboxylic acids act 
by causing some form of fatty, or "lipid" degeneration of the 
cell. The apparent association of diminished melanogenic activ-
ity with lipid accumulation within, and ultimate disappearance, 
in turn, of this type of melanocyte, suggests a link between the 
tyrosinase-inhibitory effect of dicarboxylic' acids and a cytotoxic 
effect, of, as yet, obscure mechanism. Further observations in 
this area are necessary. 
The fact that application of the cream had no apparent effect 
upon the great majority of melanocytes of normal skin, and 
that essentially normal melanocytes reappeared within the 
lesional area of lentigo maligna even as treatment was contin-
uing, is in line with the observation that, apart from an initial 
stimulation of melanogenesis, dicarboxylic acids have no dele-
terious effect on normal human melanocytes in tissue culture 
[15]. It would appear that the susceptibility of melanocytes to 
the effects of dicarboxylic acids is related to the presence of 
some abnormality as in lentigo maligna, and that it may vary 
with state of activity or some other, perhaps phasic features. 
The latter, whatever they might be, could account for the fact 
that some melanocytes of normal skin are affected. 
The ultrastructw'al observations in the present report are 
largely confined to the interfollicular epidermis, and melano-
cytes of pilosebaceous units were not extensively investigated 
because of the necessarily limited amount of material capable 
of being investigated in a reasonable length of time by electron 
microscopy. The clinical observations in the present cases 
clearly show no recurrence 2 yr after cessation of treatment, so, 
it seems reasonable to assume that the posttreatment condition 
of the follicles was similar to that of the interfollicular epider-
mIs. 
The question of dermal melanocytes persisting after three 
months of topical treatment obviously presents a matter for 
further investigation. It may be that here we are dealing with 
a question of depth and permeability, and should it in future 
prove possible to administer dicarboxylic acids orally without 
deleterious effects, another avenue of approach to this problem 
could be provided. 
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FIG 6. Lentigo matigna, case 3, after treatment for 6 weeks. Compared with condition before treatment, the epidermis is less disorganized, 
lymphocytes are absent, and there is little or no amorphous exudate between the cells. Melanocytes (M) are still abnormally numerous in the 
basal layer, but are much less heavily melanized, and many contain numerous lipid droplets (Li) in the cytoplasm. Scale = 8/Lm (x 2,5(0) . 
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FIG 7. Lentigo maligna, case 3, after treatment for 6 weeks. This 
s hows typical feature of many melanocytes present at this stage. The 
cytoplasm contains very few melanosomes, but numerous round lipid 
droplets (these appear as empty vacuoles, the lipid having leached 
away during processing). Scale = 211m (x 9,500). 
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FIG 8. Lentigo maligna, case 3, after treatment for 3 mo. Micrograph 
of supra basal regions of epidermis showing essentially normal organi-
zation with absence of supra basal melanocytes and lymphocytes, and 
no evidence of amorphous exudate between the cells. Scale = 4 11m (x 
2,500). 
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FIG 9. Lentigo maligna, case · 3, after treatment for 3 mo. Two 
essentially normal looking melanocytes (M) are present in a normally 
organized basal layer of the epidermis. The basal lamina is intact. Note 
fragmented remains of previous basal laminar material (B) indicating 
repair and reconstitution of epidermal-dermal junction. ·Scale = 3.6 Ilm 
(X 5,500). 
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FIG 10. Lentigo maligna, case 3, after treatment for 3 mo. Basal 
melanocyte engaged in active melanogenesis, and producing melano-
somes of normal appearance. Scale = 1.6 Ilm (x 12,500) . 
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F I G 11. Normal epidermis of volunteer following application of di-
carboxylic cream daily for 4 weeks. Two basal melanocytes (M) exhibi t-
ing degenerative features are present in the basal layer, but the great 
majority of melanocytes were unaffected by the treatment; the epider-
mal keratocytes were also evidently not affected. Scale = 5/Lm (x 
2,000). 
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